The Ruesch Center

The Ruesch Center and Medscape collaborate to cover topics essential to the practicing clinician who has an interest in gastrointestinal cancers -- by providing information on emerging treatments, practice standards, and individualized patient care.

Latest Features from The Ruesch Center


Marshall on Oncology

  • Will Adjuvant Oxaliplatin Data Change Practice in CRC?   Dr John Marshall previews the GI cancer studies being presented at ASCO with his picks for the ones to watch, and predicts that a plenary presentation may be practice-changing.
  • Mud Pies: Superfood for the Microbiome?   Too much cleanliness and sanitizing might reduce the effectiveness of our immune system, which could be a contributing cause of illness.
  • 12 Chemo Cycles: More Toxicity Than Therapy?   Dr John Marshall suggests that 12 cycles of chemotherapy in metastatic colorectal cancer exceeds what is needed for maximum tumor regression and often results in toxicity that is better avoided.